10X Genomics, Inc. (TXG)
63.80
-1.32
(-2.03%)
USD |
NASDAQ |
Aug 24, 16:00
64.34
+0.54
(+0.85%)
Pre-Market: 08:32
10X Genomics Shareholders Equity (Quarterly) : 825.55M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 825.55M |
| March 31, 2026 | 814.32M |
| December 31, 2025 | 796.33M |
| September 30, 2025 | 785.12M |
| June 30, 2025 | 773.28M |
| March 31, 2025 | 706.90M |
| December 31, 2024 | 710.13M |
| September 30, 2024 | 722.80M |
| June 30, 2024 | 724.06M |
| March 31, 2024 | 718.83M |
| December 31, 2023 | 741.04M |
| September 30, 2023 | 745.22M |
| June 30, 2023 | 793.30M |
| March 31, 2023 | 802.38M |
| December 31, 2022 | 805.74M |
| September 30, 2022 | 775.79M |
| June 30, 2022 | 783.52M |
| March 31, 2022 | 806.68M |
| Date | Value |
|---|---|
| December 31, 2021 | 817.57M |
| September 30, 2021 | 800.22M |
| June 30, 2021 | 784.59M |
| March 31, 2021 | 752.46M |
| December 31, 2020 | 739.07M |
| September 30, 2020 | 825.08M |
| June 30, 2020 | 391.27M |
| March 31, 2020 | 409.07M |
| December 31, 2019 | 420.08M |
| September 30, 2019 | 421.45M |
| June 30, 2019 | -227.95M |
| March 31, 2019 | |
| December 31, 2018 | -219.99M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | -112.51M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Twist Bioscience Corp. | 445.74M |
| Alamar Biosciences, Inc. (California) | 312.86M |
| Personalis, Inc. | 235.16M |
| Adaptive Biotechnologies Corp. | 142.91M |
| Champions Oncology, Inc. | 3.939M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.030B |
| Total Liabilities (Quarterly) | 204.52M |
| Debt to Equity Ratio | 0.0954 |
| Current Ratio | 5.693 |
| Net Debt Paydown Yield | 0.01% |